Skip to main content
SpringerLink
Log in
Book cover

Arzneiverordnungs-Report 2006 pp 641–654Cite as

Hypnotika und Sedativa

  • Chapter

  • 421 Accesses

Auszug

Auffälligste Entwicklung der Schlafmittel ist der seit 1992 zu beobachtende starke Verordnungsrückgang um etwa 70 %. Im Jahr 2005 waren die Hypnotikaverordnungen erstmals wieder auf diesem niedrigen Niveau stabil. Leichten Rückgängen bei den Benzodiazepinen standen stärkere Zunahmen bei den Benzodiazepinagonisten Zolpidem und Zopiclon gegenüber.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Becker HF, Mayer G, Penzel T (2004): Schlafstörungen und schlafbezogene Atmungsstörungen. Internist 45: 57–81.

    Article  PubMed  CAS  Google Scholar 

  • Black JE, Brooks SN, Nishino S (2004): Narcolepsy and syndromes of primary excessive daytime somnolence. Semin Neurol 24: 271–282.

    Article  PubMed  Google Scholar 

  • Clarenbach P, Steinberg R, Weeß HG, Berger M, Hajak G et al (1995): Empfehlungen zu Diagnostik und Therapie der Insomnie. Deutsche Gesellschaft für Schlafforschung und Schlafmedizin DGSM. Nervenarzt 66: 723–729.

    PubMed  CAS  Google Scholar 

  • Crestani F, Martin JR, Möhler H, Rudolph U (2000): Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131: 1251–1254.

    Article  PubMed  CAS  Google Scholar 

  • Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I (2000): Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33: 47–53.

    Article  PubMed  CAS  Google Scholar 

  • Dooley M, Plosker GL (2000): Zaleplon: a review of its use in the treatment of insomnia. Drugs 60: 413–445.

    Article  PubMed  CAS  Google Scholar 

  • Englert S, Linden M (1998): Differences in self-reported sleep complaints in elderly persons living in the community who do or do not take sleep medication. J Clin Psychiatry 59: 137–144.

    PubMed  CAS  Google Scholar 

  • Garcia-Borreguero D, Odin P, Schwarz C (2004): Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand 109: 303–317.

    Article  PubMed  CAS  Google Scholar 

  • Glass JR, Sproule BA, Herrmann N, Streiner D, Busto UE (2003): Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects. J Clin Psychopharmacol 23: 260–268.

    Article  PubMed  CAS  Google Scholar 

  • Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE (2005): Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 331: 1169.

    Article  Google Scholar 

  • Hänsel R (1987): Möglichkeiten und Grenzen pflanzlicher Arzneimittel (Phytotherapie). Dtsch Apoth Ztg 127: 2–6.

    Google Scholar 

  • Hänsel R, Volz HP (1995): Pflanzliche Mittel mit psychotroper Wirkung. In: Riederer P, Laux, G, Pöldinger, W (Hrsg): Neuropsychopharmaka, Bd 2, Springer-Verlag, Wien, S. 303–334.

    Google Scholar 

  • Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W (2003): Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98: 1371–1378.

    Article  PubMed  CAS  Google Scholar 

  • Happe S (2003): Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63: 2725–2737.

    Article  PubMed  Google Scholar 

  • Heydorn WE (2000): Zaleplon-a review of a novel sedative hypnotic used in the treatment of insomnia. Expert Opin Investig Drugs 9: 841–858.

    Article  PubMed  CAS  Google Scholar 

  • Hohagen F, Rink K, Käppler C, Schramm E, Riemann D, Weyerer S, Berger M (1993): Prevalence and treatment of insomnia in general practice. European Archives of Psychiatry and Clinical Neuroscience 242: 329–336.

    Article  PubMed  CAS  Google Scholar 

  • Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW (2004): Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 164: 1888–1896.

    Article  PubMed  Google Scholar 

  • Keup W (2004): Zolpidem und Zopiclon. Missbrauchsverschleppung von Benzodiazepin-Derivaten vermeiden. Arzneimitteltherapie 22: 236–238.

    Google Scholar 

  • Klotz U (1995): Benzodiazepin-Hypnotika; Pharmakokinetik. In: Riederer P, Laux G, Pöldinger W (Hrsg): Neuropsychopharmaka, Bd 2. Springer-Verlag, Wien, S. 135–139.

    Google Scholar 

  • Lader M (1987): Clinical Pharmacology of Benzodiazepines. Ann Rev Med 38: 19–28.

    Article  PubMed  CAS  Google Scholar 

  • Lader MH (2001): Implications of hypnotic flexibility on patterns of clinical use. Int J Clin Pract 116(Suppl): 14–19.

    Google Scholar 

  • Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M (2003): Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Br J Gen Pract 53: 923–928.

    PubMed  Google Scholar 

  • NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. http://consensus.nih.gov/2005/2005 InsomniaSOS026html. htm.

    Google Scholar 

  • Perlis ML, McCall WV, Krystal AD, Walsh JK (2004): Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 65: 1128–1137.

    Article  PubMed  CAS  Google Scholar 

  • Sateia MJ, Nowell PD (2004): Insomnia. Lancet. 364: 1959–73.

    Article  PubMed  Google Scholar 

  • Schenck CH, Mahowald MW, Sack RL (2003): Assessment and management of insomnia. JAMA 289(19): 2475–2479.

    Article  PubMed  Google Scholar 

  • Schapira AH (2004): Restless legs syndrome: an update on treatment options. Drugs 64: 149–158.

    Article  PubMed  CAS  Google Scholar 

  • Shen J, Chung SA, Kayumov L, Moller H, Hossain N, Wang X et al (2006): Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Can J Psychiatry 51: 27–34.

    PubMed  Google Scholar 

  • Simen S, Hajak G, Schlaf G, Westenhöfer J, Rodenbeck A, Bandel B, Pudel V, Rüther E (1995): Chronifizierung von Schlafbeschwerden. Nervenarzt 66: 686–695.

    PubMed  CAS  Google Scholar 

  • Soyka M, Bottlender R, Möller HJ (2000): Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 33: 138–141.

    Article  PubMed  CAS  Google Scholar 

  • Swainston Harrison T, Keating GM (2005): Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19: 65–89.

    Article  PubMed  Google Scholar 

  • Stocker HR (1967): Sedative und hypnogene Wirkung des Hopfens. Schweiz. Brau.-Rundsch. 78: 80–89.

    CAS  Google Scholar 

  • Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L (2003): New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 26: 261–282.

    Article  PubMed  CAS  Google Scholar 

  • Weyerer S, Dilling H (1991): Prevalence and treatment of insomnia in the community: Results from the upper Bavarian field study. Sleep 14: 392–398.

    PubMed  CAS  Google Scholar 

  • Wiegand MH (2003): Arzneimittelbehandlung von Schlafstörungen im Alter. Internist 44: 1187–1192.

    Article  PubMed  CAS  Google Scholar 

  • Wortelboer U, Cohrs S, Rodenbeck A, Rüther E (2002): Tolerability of hypnosedatives in older patients. Drugs Aging 19: 529–539.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Straße 9, 97078, Würzburg

    Prof.Dr.med. Martin J. Lohse

  2. Jebenstraße 3, 10623, Berlin

    Prof. Dr. med. Bruno Müller-Oerlinghausen

Authors
  1. Prof.Dr.med. Martin J. Lohse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Bruno Müller-Oerlinghausen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Lohse, M.J., Müller-Oerlinghausen, B. (2007). Hypnotika und Sedativa. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34370-7_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34370-7_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34369-1

  • Online ISBN: 978-3-540-34370-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation